Reaction
Achromobacter Infection reporting signals
As of the last recalculation, Achromobacter Infection appears in 121 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 104.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 6 | 104.0 | 104.1 |
| Tofacitinib Citrate | 5 | 68.4 | 68.4 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 4 | 57.0 | 57.0 |
| Dornase Alfa | 5 | 45.7 | 45.7 |